FIELD: chemistry.
SUBSTANCE: described are compounds of formula 
; or their pharmaceutically acceptable salts, where A is phenyl, X is CH2- or C=O; Y is O; k equals 1; m equals 0; R2 and R3 each independently represents hydrogen or alkyl, R4 is a group of formula 
or 
. Disclosed compounds have selective affinity to 5-HT6 and 5-HT2A receptors. Also described is a pharmaceutical composition containing said compounds and use of the said compounds in making a medicinal agent for treating diseased conditions of the central nervous system.
EFFECT: more effective treatment.
49 cl, 1 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CIS-2,4,5-TRIARYLIMIDAZOLINES | 2004 |
|
RU2319696C2 |
| OXAZOLIDINE ANTIBIOTICS | 2008 |
|
RU2470022C2 |
| NOVEL HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2769507C1 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| NEW DIAMIDES PYRIMIDIN-4,6 OF DICARBOXYLIC ACID FOR SELECTIVE INHIBITION OF COLLAGENASES | 2003 |
|
RU2344129C2 |
| ARYLSULPHONYL BENZODIOXANES USED FOR MODULATING 5-HT6 RECEPTOR, 5-HT RECEPTOR OR BOTH | 2005 |
|
RU2372344C2 |
| HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
| BICYCLIC HETEROCYCLES AND USE THEREOF AS HIV INTEGRASE INHIBITORS | 2005 |
|
RU2381228C2 |
| NON-PEPTIDE ANTAGONISTS GnRH | 2003 |
|
RU2329251C2 |
| HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
